Bioton Reaching Out To New Markets

Poland's pharmaceutical manufacturing base is renowned for harbouring an array of generic drugmakers focused on producing low-cost products for the mainly domestic and surrounding Central and Eastern European (CEE) markets. However, BMI recently highlighted Poland as one of the leading countries for biotechnology among the newer EU member states.[1] Arguably the largest of these companies is Bioton, which is gaining an increasingly global presence through foreign subsidiaries and

To read the full article, please choose one of the following options: